Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is a leading peer-reviewed journal dedicated to advancing the field of infectious diseases, particularly focusing on tuberculosis and other mycobacterial infections. Published by ELSEVIER in the United Kingdom with an impressive open access model since 2015, this journal aims to provide a platform for the dissemination of high-quality research, clinical findings, and innovative methodologies in the management of mycobacterial diseases. With a commendable impact, the journal currently holds a Q2 ranking in multiple categories including Infectious Diseases and Pulmonary and Respiratory Medicine, reflecting its influence in the academic community. The journal is dedicated to serving researchers, healthcare professionals, and students by offering access to essential information that can improve patient outcomes and enhance public health strategies. As the field of mycobacterial diseases continues to evolve, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases remains a crucial resource for those seeking to remain at the forefront of research and clinical practice.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.